Bladder Cancer Journal Vol. 8, Issue 4
Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer:...
Read More
2022
PCa Commentary | Volume 172 – December 2022
This Commentary discusses selecting men for MDT+ADT versus MDT alone in the oligometastatic prostate cancer space.
Read More
Enhanced Techniques of NMIBC Detection
Dr. Mark D. Tyson, II, MD, MPH, moderates this session by discussing the critical need for precise detection techniques in managing NMIBC.
Read More
Use of Biomarkers in NMIBC: What’s New and What Should We Use?
Dr. Peter C. Black moderated an insightful panel discussion exploring the latest advancements in the use of biomarkers for non-muscle invasive bladder cancer (NMIBC) and their potential integration into clinical practice.
Read More
Biomarker Integration for Advanced Urothelial Carcinoma
Dr. Donna E. Hansel, MD, PhD delves into the critical role of biomarker integration in the management of advanced urothelial carcinoma.
Read More